CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Predict-IV aims to enhance drug safety assessment by integrating non-animal testing methods and computational models. The project focuses on identifying early biomarkers of toxicity and improving in vitro testing for pharmaceuticals targeting organs like the liver and kidney.
The overall aim of Predict-IV is to develop strategies to improve the assessment of drug safety in the early stage of development and late discovery phase, by an intelligent combination of non animal-based test systems, cell biology, mechanistic toxicology and in-silico modelling, in a rapid and cost effective manner. A better prediction of the safety of an investigational compound in early development will be delivered.
Margins-of-safety will be deduced and the data generated by the proposed ap…
JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, DARMSTADT
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Austria, Innsbruck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Roma
Type: Research institute
Activity type: Research Organisations
SME: No
INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES - INERIS
France, Verneuil En Halatte
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
